Pfizer Long Term Debt 1986-2025 | PFE
Pfizer long term debt from 1986 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- Pfizer long term debt for the quarter ending September 30, 2025 was $57.409B, a 1.02% decline year-over-year.
- Pfizer long term debt for 2024 was $57.405B, a 6.72% decline from 2023.
- Pfizer long term debt for 2023 was $61.538B, a 87.14% increase from 2022.
- Pfizer long term debt for 2022 was $32.884B, a 9.15% decline from 2021.
Pfizer Annual Long Term Debt
(Millions of US $) |
| 2024 |
$57,405 |
| 2023 |
$61,538 |
| 2022 |
$32,884 |
| 2021 |
$36,195 |
| 2020 |
$37,133 |
| 2019 |
$35,955 |
| 2018 |
$32,909 |
| 2017 |
$33,538 |
| 2016 |
$31,398 |
| 2015 |
$28,740 |
| 2014 |
$31,541 |
| 2013 |
$30,462 |
| 2012 |
$31,036 |
| 2011 |
$34,926 |
| 2010 |
$38,410 |
| 2009 |
$43,193 |
| 2008 |
$7,963 |
| 2007 |
$7,314 |
| 2006 |
$5,546 |
| 2005 |
$6,347 |
| 2004 |
$7,279 |
| 2003 |
$5,755 |
| 2002 |
$3,140 |
| 2001 |
$2,609 |
| 2000 |
$1,123 |
| 1999 |
$525 |
| 1998 |
$527 |
| 1997 |
$729 |
| 1996 |
$687 |
| 1995 |
$833 |
| 1994 |
$604 |
| 1993 |
$571 |
| 1992 |
$571 |
| 1991 |
$397 |
| 1990 |
$193 |
| 1989 |
$191 |
| 1988 |
$227 |
| 1987 |
$249 |
| 1986 |
$285 |
| 1985 |
$324 |
Pfizer Quarterly Long Term Debt
(Millions of US $) |
| 2025-09-30 |
$57,409 |
| 2025-06-30 |
$57,502 |
| 2025-03-31 |
$57,639 |
| 2024-12-31 |
$57,405 |
| 2024-09-30 |
$58,002 |
| 2024-06-30 |
$57,506 |
| 2024-03-31 |
$61,307 |
| 2023-12-31 |
$61,538 |
| 2023-09-30 |
$61,048 |
| 2023-06-30 |
$61,356 |
| 2023-03-31 |
$31,704 |
| 2022-12-31 |
$32,884 |
| 2022-09-30 |
$32,629 |
| 2022-06-30 |
$34,294 |
| 2022-03-31 |
$35,656 |
| 2021-12-31 |
$36,195 |
| 2021-09-30 |
$36,250 |
| 2021-06-30 |
$35,354 |
| 2021-03-31 |
$35,347 |
| 2020-12-31 |
$37,133 |
| 2020-09-30 |
$49,785 |
| 2020-06-30 |
$50,529 |
| 2020-03-31 |
$36,281 |
| 2019-12-31 |
$35,955 |
| 2019-09-30 |
$36,044 |
| 2019-06-30 |
$36,168 |
| 2019-03-31 |
$35,733 |
| 2018-12-31 |
$32,909 |
| 2018-09-30 |
$33,652 |
| 2018-06-30 |
$28,935 |
| 2018-03-31 |
$31,831 |
| 2017-12-31 |
$33,538 |
| 2017-09-30 |
$34,503 |
| 2017-06-30 |
$34,191 |
| 2017-03-31 |
$36,330 |
| 2016-12-31 |
$31,398 |
| 2016-09-30 |
$30,437 |
| 2016-06-30 |
$30,457 |
| 2016-03-31 |
$27,824 |
| 2015-12-31 |
$28,740 |
| 2015-09-30 |
$29,079 |
| 2015-06-30 |
$26,729 |
| 2015-03-31 |
$29,370 |
| 2014-12-31 |
$31,541 |
| 2014-09-30 |
$31,666 |
| 2014-06-30 |
$32,267 |
| 2014-03-31 |
$27,649 |
| 2013-12-31 |
$30,462 |
| 2013-09-30 |
$31,812 |
| 2013-06-30 |
$31,532 |
| 2013-03-31 |
$31,481 |
| 2012-12-31 |
$31,036 |
| 2012-09-30 |
$31,083 |
| 2012-06-30 |
$30,868 |
| 2012-03-31 |
$33,543 |
| 2011-12-31 |
$34,926 |
| 2011-09-30 |
$35,399 |
| 2011-06-30 |
$35,723 |
| 2011-03-31 |
$35,308 |
| 2010-12-31 |
$38,410 |
| 2010-09-30 |
$39,010 |
| 2010-06-30 |
$37,765 |
| 2010-03-31 |
$38,281 |
| 2009-12-31 |
$43,193 |
| 2009-09-30 |
$32,402 |
| 2009-06-30 |
$31,864 |
| 2009-03-31 |
$21,064 |
| 2008-12-31 |
$7,963 |
| 2008-09-30 |
$7,152 |
| 2008-06-30 |
$7,246 |
| 2008-03-31 |
$8,143 |
| 2007-12-31 |
$7,314 |
| 2007-09-30 |
$6,041 |
| 2007-06-30 |
$5,777 |
| 2007-03-31 |
$4,771 |
| 2006-12-31 |
$5,546 |
| 2006-09-30 |
$5,561 |
| 2006-06-30 |
$5,450 |
| 2006-03-31 |
$6,508 |
| 2005-12-31 |
$6,347 |
| 2005-09-30 |
$5,414 |
| 2005-06-30 |
$5,517 |
| 2005-03-31 |
$6,432 |
| 2004-12-31 |
$7,279 |
| 2004-09-30 |
$7,956 |
| 2004-06-30 |
$6,765 |
| 2004-03-31 |
$7,144 |
| 2003-12-31 |
$5,755 |
| 2003-09-30 |
$6,439 |
| 2003-06-30 |
$6,710 |
| 2003-03-31 |
$3,713 |
| 2002-12-31 |
$3,140 |
| 2002-09-30 |
$3,118 |
| 2002-06-30 |
$3,072 |
| 2002-03-31 |
$2,580 |
| 2001-12-31 |
$2,609 |
| 2001-09-30 |
$2,087 |
| 2001-06-30 |
$2,367 |
| 2001-03-31 |
$1,888 |
| 2000-12-31 |
$1,123 |
| 2000-09-30 |
$1,257 |
| 2000-06-30 |
$1,266 |
| 2000-03-31 |
$524 |
| 1999-12-31 |
$525 |
| 1999-09-30 |
$525 |
| 1999-06-30 |
$530 |
| 1999-03-31 |
$525 |
| 1998-12-31 |
$527 |
| 1998-09-30 |
$528 |
| 1998-06-30 |
$724 |
| 1998-03-31 |
$729 |
| 1997-12-31 |
$729 |
| 1997-09-30 |
$729 |
| 1997-06-30 |
$731 |
| 1997-03-31 |
$732 |
| 1996-12-31 |
$687 |
| 1996-09-30 |
$553 |
| 1996-06-30 |
$583 |
| 1996-03-31 |
$584 |
| 1995-12-31 |
$833 |
| 1995-09-30 |
$358 |
| 1995-06-30 |
$611 |
| 1995-03-31 |
$610 |
| 1994-12-31 |
$604 |
| 1994-09-30 |
$586 |
| 1994-06-30 |
$570 |
| 1994-03-31 |
$570 |
| 1993-12-31 |
$571 |
| 1993-09-30 |
$573 |
| 1993-06-30 |
$574 |
| 1993-03-31 |
$574 |
| 1992-12-31 |
$571 |
| 1992-09-30 |
$592 |
| 1992-06-30 |
$581 |
| 1992-03-31 |
$580 |
| 1991-12-31 |
$397 |
| 1991-09-30 |
$149 |
| 1991-06-30 |
$157 |
| 1991-03-31 |
$177 |
| 1990-12-31 |
$193 |
| 1990-09-30 |
$190 |
| 1990-06-30 |
$182 |
| 1990-03-31 |
$190 |
| 1989-12-31 |
$191 |
| 1989-09-30 |
$207 |
| 1989-06-30 |
$214 |
| 1989-03-31 |
$221 |
| 1988-12-31 |
$227 |
| 1988-09-30 |
$232 |
| 1988-06-30 |
$245 |
| 1988-03-31 |
$330 |
| 1987-12-31 |
$249 |
| 1987-09-30 |
$252 |
| 1987-06-30 |
$273 |
| 1987-03-31 |
$280 |
| 1986-12-31 |
$285 |
| 1985-12-31 |
$324 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$201.199B |
$100.330B |
|
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
|
